Press

Shareholders News AMI / Calls for projects Conferences Events Institutional Media / Videos Uncategorized Join us Partners Press SATT Network Start-ups Technologies / Projects

Uncategorized Press

New technology revolutionizes water quality biomonitoring

SATT Nord announces the signing of an exclusive operating license for […]

Read more

A new breakthrough in the treatment of cystic fibrosis

An exclusive license agreement has been signed between SATT Nord and […]

Read more

What if tomorrow's photovoltaic technology became invisible and was integrated into our screens and windows?

An exclusive license agreement has been signed between SATT Nord and […]

Read more

New innovative regenerative biotherapy for the treatment of neurodegenerative diseases

Read more

SATT Nord is leading an academic partnership in collaboration with Boehringer Ingelheim to develop a new treatment for people with pulmonary fibrosis.

Read more

Apmonia Therapeutics announces a new licensing agreement with SATT Nord to strengthen its portfolio of innovative peptides in oncology

Read more